Advertisement

Maternal Sleep in Pregnancy and Postpartum Part II: Biomechanisms and Intervention Strategies

  • Judith E. CarrollEmail author
  • Douglas M. Teti
  • Martica H. Hall
  • Lisa M. Christian
Reproductive Psychiatry and Women's Health (CN Epperson and L Hantsoo, Section Editors)
  • 84 Downloads
Part of the following topical collections:
  1. Topical Collection on Reproductive Psychiatry and Women's Health

Abstract

Purpose of Review

As described in Part I of this two-part review, maternal sleep has wide-ranging implications for maternal health and overall family functioning. In addition, poor sleep quality and insufficient sleep are highly prevalent and characterized by considerable racial disparities.

Recent Findings

Part II of this review discusses physiological mechanisms, including inflammation and appetite hormones, by which sleep impacts multiple facets of women’s health during pregnancy and postpartum. These mechanisms are increasingly being delineated, but require further study and better integration with studies of behavioral and physical health outcomes. Further, there are multiple potential strategies for improving maternal sleep, providing the opportunity to tailor treatment approaches to individual needs.

Summary

Ultimately, as a critical health behavior that is amenable to intervention, sleep provides a promising future direction for measurably impacting clinically relevant health parameters in women of childbearing age.

Keywords

Sleep Perinatal Inflammation Cellular aging Intervention Cognitive-behavioral therapy Nutrition Exercise Infant Maternal 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

  1. 1.
    López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–217.CrossRefGoogle Scholar
  2. 2.
    Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009;8(1):18–30.Google Scholar
  3. 3.
    Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80(1):40–52.CrossRefGoogle Scholar
  4. 4.
    Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006;166:1756–62.CrossRefGoogle Scholar
  5. 5.
    Okun ML, Hall M, Coussons-Read ME. Sleep disturbances increase interleukin-6 production during pregnancy: implications for pregnancy complications. Reprod Sci. 2007;14:560–7.CrossRefGoogle Scholar
  6. 6.
    Blair LM, Porter K, Leblebicioglu B, Christian LM. Poor sleep quality and associated inflammation predict preterm birth: heightened risk among African Americans. Sleep. 2015;38(8):1259–67.CrossRefGoogle Scholar
  7. 7.
    Christian LM, Kowalsky JM, Mitchell AM, Porter K. Associations of postpartum sleep, stress, and depressive symptoms with LPS-stimulated cytokine production among African American and White women. J Neuroimmunol. 2018;316:98–106.CrossRefGoogle Scholar
  8. 8.
    Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW, Wallace K, et al. The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond). 2016;130(6):409–19.Google Scholar
  9. 9.
    Nadeau-Vallée M, Obari D, Palacios J, Brien M-È, Duval C, Chemtob S, et al. Sterile inflammation and pregnancy complications: a review. Reproduction. 2016;152(6):R277–92.Google Scholar
  10. 10.
    Kalagiri RR, Carder T, Choudhury S, Vora N, Ballard AR, Govande V, et al. Inflammation in complicated pregnancy and its outcome. Am J Perinatol. 2016;33(14):1337–56.Google Scholar
  11. 11.
    Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31.CrossRefGoogle Scholar
  12. 12.
    Osborne LM, Monk C. Perinatal depression--the fourth inflammatory morbidity of pregnancy?: theory and literature review. Psychoneuroendocrinology. 2013;38(10):1929–52.CrossRefGoogle Scholar
  13. 13.
    Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Carpenter M, Heiss G. Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults--the ARIC study. Atherosclerosis Risk in Communities. Obes Res. 2000;8(4):279–86.CrossRefGoogle Scholar
  14. 14.
    Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Heiss G, A.R.C. S. Inflammation markers predict increased weight gain in smoking quitters. Obes Res. 2003;11(11):1339–44.CrossRefGoogle Scholar
  15. 15.
    Barzilay JI, Forsberg C, Heckbert SR, Cushman M, Newman AB. The association of markers of inflammation with weight change in older adults: the cardiovascular health study. Int J Obes. 2006;30(9):1362–7.CrossRefGoogle Scholar
  16. 16.
    Holz T, Thorand B, Doring A, Schneider A, Meisinger C, Koenig W. Markers of inflammation and weight change in middle-aged adults: results from the prospective MONICA/KORA S3/F3 study. Obesity. 2010;18(12):2347–53.CrossRefGoogle Scholar
  17. 17.
    Engstrom G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgarde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes. 2003;52(8):2097–101.CrossRefGoogle Scholar
  18. 18.
    Kong LC, Wuillemin PH, Bastard JP, Sokolovska N, Gougis S, Fellahi S, et al. Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach. Am J Clin Nutr. 2013;98(6):1385–94.Google Scholar
  19. 19.
    Popa C, Netea MG, Radstake TRDS, van Riel PL, Barrera P, van der Meer JWM. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis. 2005;64(8):1195–8.CrossRefGoogle Scholar
  20. 20.
    van Crevel R, Karyadi E, Netea MG, Verhoef H, Nelwan RH, West CE, et al. Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation. J Clin Endocrinol Metab. 2002;87(2):758–63.Google Scholar
  21. 21.
    Chen K, Li FH, Li J, Cai HB, Strom S, Bisello A, et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med. 2006;12(4):425–32.Google Scholar
  22. 22.
    Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4–9.CrossRefGoogle Scholar
  23. 23.
    Freund A, Orjalo AV, Desprez P-Y, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010;16(5):238–46.CrossRefGoogle Scholar
  24. 24.
    Menon R, Behnia F, Polettini J, Saade GR, Campisi J, Velarde M. Placental membrane aging and HMGB1 signaling associated with human parturition. Aging. 2016;8:216–30.CrossRefGoogle Scholar
  25. 25.
    Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 2005;120:513–22.CrossRefGoogle Scholar
  26. 26.
    Carroll JE, Cole SW, Seeman TE, Breen EC, Witarama T, Arevalo JM, et al. Partial sleep deprivation activates the DNA damage response (DDR) and the senescence-associated secretory phenotype (SASP) in aged adult humans. Brain Behav Immun. 2016;51:223–9.Google Scholar
  27. 27.
    Carreras A, Zhang SX, Peris E, Qiao Z, Gileles-Hillel A, Li RC, et al. Chronic sleep fragmentation induces endothelial dysfunction and structural vascular changes in mice. Sleep. 2014;37(11):1817–24.Google Scholar
  28. 28.
    Carroll JE, Esquivel S, Goldberg A, Seeman TE, Effros RB, Dock J, et al. Insomnia and telomere length in older adults. Sleep. 2016;39(3):559–64.Google Scholar
  29. 29.
    Prather AA, Puterman E, Lin J, O'Donovan A, Krauss J, Tomiyama AJ, et al. Shorter leukocyte telomere length in midlife women with poor sleep quality. J Aging Res. 2011;2011:721390.Google Scholar
  30. 30.
    Carroll JE, Irwin MR, Levine M, Seeman TE, Absher D, Assimes T, et al. Epigenetic aging and immune senescence in women with insomnia symptoms: findings from the Women’s Health Initiative Study. Biol Psychiatry. 2017;81(2):136–44.Google Scholar
  31. 31.
    Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Investig. 1990;85(5):1392–400.CrossRefGoogle Scholar
  32. 32.
    Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, et al. Cognitive-behavior therapy, singly and combined with medication, for persistent insomnia: acute and maintenance therapeutic effects. JAMA. 2009;301(19):2005–15.Google Scholar
  33. 33.
    Sedov ID, Goodman SH, Tomfohr-Madsen LM. Insomnia treatment preferences during pregnancy. J Obstet Gynecol Neonatal Nurs. 2017;46(3):e95–e104.CrossRefGoogle Scholar
  34. 34.
    Tomfohr-Madsen LM, Clayborne ZM, Rouleau CR, Campbell TS. Sleeping for two: an open-pilot study of cognitive behavioral therapy for insomnia in pregnancy. Behav Sleep Med. 2017;15(5):377–93.CrossRefGoogle Scholar
  35. 35.
    Ong JC, Manber R, Segal Z, Xia Y, Shapiro S, Wyatt JK. A randomized controlled trial of mindfulness meditation for chronic insomnia. Sleep. 2014;37(9):1553–63.CrossRefGoogle Scholar
  36. 36.
    Ong J, Sholtes D. A mindfulness-based approach to the treatment of insomnia. J Clin Psychol. 2010;66(11):1175–84.CrossRefGoogle Scholar
  37. 37.
    Garland SN, Zhou ES, Gonzalez BD, Rodriguez N. The quest for mindful sleep: a critical synthesis of the impact of mindfulness-based interventions for insomnia. Curr Sleep Med Rep. 2016;2:142–51.Google Scholar
  38. 38.
    Bower JE, Irwin MR. Mind-body therapies and control of inflammatory biology: a descriptive review. Brain Behav Immun. 2016;51:1–11.CrossRefGoogle Scholar
  39. 39.
    Sadja J, Mills PJ. Effects of yoga interventions on fatigue in cancer patients and survivors: a systematic review of randomized controlled trials. Explore (NY). 2013;9:232–43.CrossRefGoogle Scholar
  40. 40.
    Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Breen EC, Witarama T, et al. Cognitive behavioral therapy vs. tai chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial. Sleep. 2014;37:1543–52.Google Scholar
  41. 41.
    Irwin MR, Olmstead R, Breen EC, Witarama T, Carrillo C, Sadeghi N, et al. Cognitive behavioral therapy and tai chi reverse cellular and genomic markers of inflammation in late life insomnia: a randomized controlled trial. Biol Psychiatry. 2015;78:721–9.Google Scholar
  42. 42.
    Sheffield KM, Woods-Giscombé CL. Efficacy, feasibility, and acceptability of perinatal yoga on women’s mental health and well-being. J Holist Nurs. 2016;34:64–79.CrossRefGoogle Scholar
  43. 43.
    Miles EA, Noakes PS, Kremmyda LS, Vlachava M, Diaper ND, Rosenlund G, et al. The salmon in pregnancy study: study design, subject characteristics, maternal fish and marine n-3 fatty acid intake, and marine n-3 fatty acid status in maternal and umbilical cord blood. Am J Clin Nutr. 2011;94(6):1986s–92s.Google Scholar
  44. 44.
    Jorgensen MH, Nielsen PK, Michaelsen KF, Lund P, Lauritzen L. The composition of polyunsaturated fatty acids in erythrocytes of lactating mothers and their infants. Matern Child Nutr. 2006;2(1):29–39.Google Scholar
  45. 45.
    Leung BM, Kaplan BJ. Perinatal depression: prevalence, risks, and the nutrition link--a review of the literature. J Am Diet Assoc. 2009;109(9):1566–75.CrossRefGoogle Scholar
  46. 46.
    Yee LD, Lester JL, Cole RM, Richardson JR, Hsu JC, Li Y, et al. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Am J Clin Nutr. 2010;91(5):1185–94.Google Scholar
  47. 47.
    Yehuda S, Rabinovitz-Shenkar S, Carasso RL. Effects of essential fatty acids in iron deficient and sleep-disturbed attention deficit hyperactivity disorder (ADHD) children. Eur J Clin Nutr. 2011;65(10):1167–9.CrossRefGoogle Scholar
  48. 48.
    Papandreou C. Independent associations between fatty acids and sleep quality among obese patients with obstructive sleep apnoea syndrome. J Sleep Res. 2013;22(5):569–72.CrossRefGoogle Scholar
  49. 49.
    Fagioli I, Baroncini P, Ricour C, Salzarulo P. Decrease of slow-wave sleep in children with prolonged absence of essential lipids intake. Sleep. 1989;12(6):495–9.PubMedGoogle Scholar
  50. 50.
    Hall WL, Hay G, Maniou Z, Seed PT, Chowienczyk PJ, Sanders TAB. Effect of low doses of long chain n-3 polyunsaturated fatty acids on sleep-time heart rate variability: a randomized, controlled trial. Int J Cardiol. 2013;168(4):4439–42.CrossRefGoogle Scholar
  51. 51.
    Lavialle M, Champeil-Potokar G, Alessandri JM, Balasse L, Guesnet P, Papillon C, et al. An (n-3) polyunsaturated fatty acid-deficient diet disturbs daily locomotor activity, melatonin rhythm, and striatal dopamine in Syrian hamsters. J Nutr. 2008;138(9):1719–24.Google Scholar
  52. 52.
    Ladesich JB, Pottala JV, Romaker A, Harris WS. Membrane level of omega-3 docosahexaenoic acid is associated with severity of obstructive sleep apnea. J Clin Sleep Med. 2011;7(4):391–6.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Zaouali-Ajina M, Gharib A, Durand G, Gazzah N, Claustrat B, Gharib C, et al. Dietary docosahexaenoic acid-enriched phospholipids normalize urinary melatonin excretion in adult (n-3) polyunsaturated fatty acid-deficient rats. J Nutr. 1999;129(11):2074–80.Google Scholar
  54. 54.
    Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev. 2010;68(5):280–9.CrossRefGoogle Scholar
  55. 55.
    Gradisar M, Jackson K, Spurrier NJ, Gibson J, Whitham J, Williams AS, et al. Behavioral interventions for infant sleep problems: a randomized controlled trial. Pediatrics. 2016;137:e20151486.Google Scholar
  56. 56.
    Mindell JA, Leichman ES, Lee C, Williamson AA, Walters RM. Implementation of a nightly bedtime routine: how quickly do things improve? Infant Behav Dev. 2017;49:220–7.CrossRefGoogle Scholar
  57. 57.
    Voltaire, S., Teti, D., Crosby, B., & Bangs, K., Observed family processes at bedtime: relation to infant sleep quality at 12 months, in 9th biennial conference of Pediatric Sleep Medicine. 2017: Amelia Island, FL.Google Scholar
  58. 58.
    Feinberg ME, Kan ML. Establishing family foundations: intervention effects on coparenting, parent/infant well-being, and parent–child relations. J Fam Psychol. 2008;22(2):253–63.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Judith E. Carroll
    • 1
    • 2
    Email author
  • Douglas M. Teti
    • 3
  • Martica H. Hall
    • 4
  • Lisa M. Christian
    • 5
    • 6
  1. 1.Psychiatry and Biobehavioral SciencesUniversity of California – Los AngelesLos AngelesUSA
  2. 2.Cousins Center for PsychoneuroimmunologyUCLA Semel Institute for Neuroscience & Human BehaviorLos AngelesUSA
  3. 3.Department of Human Development and Family StudiesThe Pennsylvania State UniversityState CollegeUSA
  4. 4.Department of PsychiatryThe University of PittsburghPittsburghUSA
  5. 5.Department of Psychiatry & Behavioral HealthThe Ohio State University Wexner Medical CenterColumbusUSA
  6. 6.The Institute for Behavioral Medicine ResearchThe Ohio State University Wexner Medical CenterColumbusUSA

Personalised recommendations